openPR Logo
Press release

Cholera Vaccine Market to growing at CAGR of 15.6% by 2025, Top Prominent Players: Valneva SE, Emergent BioSolutions, Inc. (PaxVax, Inc.), Astellas Pharma, Inc., Sanofi (Shantha Biotechnics Private Limited)

04-23-2020 11:21 AM CET | Health & Medicine

Press release from: Allied Market Research

Cholera Vaccine Market

Cholera Vaccine Market

UPDATE AVAILABLE ON-DEMAND

The global cholera vaccine market generated $65 million in 2017, and is projected to reach $207 million by 2025, growing at a CAGR of 15.6% from 2018 to 2025. The Dukoral segment accounted around half of the total market share in 2017.

Cholera is an acute, profusely watery diarrhea caused by Vibrio cholera and spreads through contamination of water and food. In addition, it is closely associated with poor sanitation and lack of clean drinking water. The number of global cholera disease cases accounts for around 35 million every year. Currently, the frequency of cholera epidemics has increased mainly in low- and middle-income countries. Cholera control is the main priority in cholera-endemic areas, which in turn increase the demand for the cholera vaccines.

Download Report Sample (320 Pages PDF with Insights) @ https://www.alliedmarketresearch.com/request-sample/5177

The cholera vaccine market is expected to exhibit significant growth during the forecast period due to lack of proper sanitation & consumption of contaminated food and growth in awareness about cholera preventive care. In addition, development of novel approaches for new cholera vaccine further drive the market growth. However, risk of adverse effects and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, high growth opportunities in untapped markets are expected to offer significant profitable opportunities for the market players in the near future.

Based on end user, the market is categorized into hospitals & clinics, research & academic laboratories, and others. The hospitals & clinics segment presently dominates the market, and is expected to remain dominant during the forecast period. This is attributed to the fact that hospitals and clinics are authorized to organize campaigns for cholera vaccination, as the number of cases for cholera diseases is rapidly growing in LMICs.

Asia-Pacific was the leading revenue contributor to the global cholera vaccine market in 2017, and is expected to remain dominant throughout the forecast period due to increase in the prevalence of cholera disease and rise in importance of immunization. However, North America is expected to grow at the highest CAGR during the study period. This is attributed to the launch of the first and only oral cholera vaccine, Vaxchora, in the USA. Furthermore, the number of travelers to the cholera-affected countries is increasing, which in turn increases the demand for immunization.

Inquire More About This Report Before Making Decision To Purchase @ https://www.alliedmarketresearch.com/purchase-enquiry/5177

The Major Key Players Are:

Valneva SE, Emergent BioSolutions, Inc. (PaxVax, Inc.), Astellas Pharma, Inc., Sanofi (Shantha Biotechnics Private Limited), Eubiologics Co., Ltd., and Johnson & Johnson (Crucell), Celldex Therapeutics, Inc.

The other Key players are:

Merck & Co., Inc., GlaxoSmithKline plc., and others.

Key Findings Of The Study:

o Based on product, the Vaxchora segment is expected to experience rapid growth in the market, and is projected to grow at a CAGR of 17.4% from 2018 to 2025.
o Depending on end user, the pharmaceutical & biotechnology companies segment is expected to exhibit the highest CAGR during the forecast period.
o U.S. generated the highest revenue in the global cholera vaccine market industry in 2017, accounting less than one-tenth of the global market in 2017.
o North America is estimated to grow at a CAGR of 17.1% during the forecast period.

Access Full Report @ https://www.alliedmarketresearch.com/cholera-vaccine-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cholera Vaccine Market to growing at CAGR of 15.6% by 2025, Top Prominent Players: Valneva SE, Emergent BioSolutions, Inc. (PaxVax, Inc.), Astellas Pharma, Inc., Sanofi (Shantha Biotechnics Private Limited) here

News-ID: 2021945 • Views: 683

More Releases from Allied Market Research

Smart Beacon Market Expected to Reach $103.94 Billion By 2030 at 37.7% CAGR | Gr …
Rise in modern-day communication technologies, surge in investments in proximity marketing, and increase in adoption of smart devices are the factors that drive the global smart beacon market growth. As per the report published by Allied Market Research, the global smart beacon market generated $3.28 billion in 2020, and is estimated to reach $103.94 billion by 2030, witnessing a CAGR of 37.7% from 2021 to 2030. The report provides a
Fantasy Sports Market in Asia-Pacific & Canada is Expected to Reach $3,739.8 Mil …
According to a new report published by Allied Market Research, titled, “Asia-Pacific & Canada Fantasy Sports Market by Sports Type, Platform, and Demographic: Regional Opportunity Analysis and Industry Forecast, 2021–2027,” Asia-Pacific & Canada fantasy sports market size was valued at $2,021.9 million in 2019, and is projected to reach $3,739.8 million by 2027, growing at a CAGR of 10.7% from 2021 to 2027. Fantasy sport is played using internet where participants
Hammock Market Size Is Projected Reach $639.8 Million By 2030, Registering At A …
Surge in hiking and adventure tourism, rise in demand from residential segment, and expansion of hospitality industry drive the growth of the global hammock market. North America contributed to the highest share in terms of revenue in 2020. The outbreak of the COVID-19 pandemic has resulted in transition of consumers toward online sales channels to purchase campaigning gear products including hammocks. According to the report published by Allied Market Research, the
Cotton Personal-Care Product Market 2021: Top Factors That Are Leading The Deman …
A lead analyst at AMR highlighted the market across Europe region is expected to dominate in terms of revenues throughout the forecast period. Allied Market Research published a research report on the Cotton personal-care product market. The findings of the report states that the global market for Cotton personal-care product is expected to reach $19.15 billion by 2028, manifesting a CAGR of 4.6% from 2020 to 2028. The report provides valuable

All 5 Releases


More Releases for Cholera

Oral Cholera Vaccine Market is Thriving Worldwide with Top Companies like: Sanof …
Los Angeles, United State, –The report titled Global Oral Cholera Vaccine Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Oral Cholera Vaccine market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of
Global Cholera Vaccines Market Review 2018-2023 Merck, PaxVax, Valneva
A market study "Global Cholera Vaccines Market" examines the performance of the Cholera Vaccines market 2018. It encloses an in-depth Research of the Cholera Vaccines market state and the competitive landscape globally. This report analyzes the potential of Cholera Vaccines market in the present and the future prospects from various angles in detail. The Global Cholera Vaccines Market 2018 report includes Cholera Vaccines market Revenue, market Share, Cholera Vaccines industry volume,
Cholera Vaccine Market Expecting an Outstanding Growth Till 2022
QY Research Groups’ expert research analysts estimate the Cholera Vaccine Market to grow at a substantial Compound Annual Growth Rate (CAGR) throughout the forecast period 2017 to 2022. The report ‘Global Cholera Vaccine Market Research Report 2017’ centers on essential expertise of Global Cholera Vaccine segment. The potential of the segment has been examined along with the key challenges. The current market scenario and the future prognosis of the segment has
Cholera Treatment Market - Detailed Study Analysis and Forecast by 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular
Cholera Treatment Market Growth Report 2016- 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular
Cholera Treatment Market: Brand Analysis and Forecast upto 2024
Cholera disease spreads because of contamination of water and food and is closely associated with poor sanitation and lack of clean drinking water. The global disease burden is around 3–5 million cases and 100 000– 130 000 deaths per year. In recent time the frequency of cholera epidemics has increased. The disease is caused by Vibrio cholerae a rod-shaped waterborne bacterium. The toxins released by bacterium causes loss of intravascular